SCHEDULE: JPMorgan Chase Discloses 1.7% Stake in Hims & Hers Health

JPMorgan Chase & Co. reported a 1.7% beneficial ownership stake in Hims & Hers Health, Inc. as of February 27, 2026.

Summary

• JPMorgan Chase & Co. reported beneficial ownership of 3,881,790 shares of Hims & Hers Health, Inc. Class A common stock.
• This represents 1.7% of the total outstanding Class A common stock.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported position.
• JPMorgan Chase & Co. holds sole voting power over 3,399,965 shares and shared voting power over 13 shares.
• JPMorgan Chase & Co. holds sole dispositive power over 3,879,553 shares and shared dispositive power over 2,145 shares.
• The filing was made by JPMorgan Chase & Co. as a parent holding company, in accordance with Rule 240.13d-1(b)(1)(ii)(G).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as it confirms continued institutional interest from a major financial entity in Hims & Hers Health, Inc.

Positives

• The disclosure of institutional ownership by a major financial institution like JPMorgan Chase & Co. can be viewed as a vote of confidence in Hims & Hers Health, Inc.

Negatives

• No specific negative information about Hims & Hers Health, Inc. is contained within this beneficial ownership report.

Risks

• No specific risks related to Hims & Hers Health, Inc. are detailed in this beneficial ownership report.

Future Outlook

No forward-looking statements or guidance from Hims & Hers Health, Inc. are provided in this beneficial ownership report.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by institutional investors holding a significant stake in a company, or amendments to previous filings. JPMorgan Chase & Co.'s reported stake in Hims & Hers Health, Inc. reflects its investment activities across various subsidiaries, which is common for large financial conglomerates.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which can influence market perception and liquidity.

Key Dates

Keywords

Hims & Hers Health, JPMorgan Chase, Schedule 13G, beneficial ownership, Class A common stock, institutional ownership, healthcare technology